L
ADING

Finance & Investment

Stopping Market Data Costs Going Rogue
Stopping Market Data Costs Going Rogue
Tim Versteeg, Chief Sales Officer APAC at NeoXam gives us his thoughts on whether Regional Banks across the APAC region
Read more.
AIMA Signs MoU With IAMAC
AIMA Signs MoU With IAMAC
AIMA Signs MoU With Insurance Asset Management Association Of China (IAMAC)
Read more.
Taxing Work
Taxing Work
Following the firm's success in winning the Tax Advisor of the Year - Pacific Alliance accolade, we interviewed its Chairman
Read more.
India's Currency Move
India’s Currency Move
By Kannan Venkataramani, Senior Portfolio Manager Asian Equity at NN Investment Partners
Read more.
MoneyGram Extends Cash to Account Footprint in the Philippines
MoneyGram Extends Cash to Account Footprint in the Philippines
MoneyGram Extends Cash to Account Footprint in the Philippines
Read more.
Cambodia-APN Co-Finance Partnership to Benefit
Cambodia-APN Co-Finance Partnership to Benefit
Cambodia-APN Co-Finance Partnership to Benefit Researchers in the Region
Read more.
Asia Pacific’s Building Stock - 82.6 Billion Square Meters
Asia Pacific’s Building Stock – 82.6 Billion Square Meters
A recent report from Navigant Research offers a comprehensive view of the world's total commercial and residential building stock with
Read more.
New Mastercard Partnership in China
New Mastercard Partnership in China
First-ever collaboration with CDRF seeks to improve financial literacy and entrepreneurial skills.
Read more.
Elderly Healthcare in Asia Pacific Will Cost US$20 Trillion over the Next 15 Years
Elderly Healthcare in Asia Pacific Will Cost US$20 Trillion over the Next 15 Years
Elderly healthcare in the Asia Pacific region will cost more than US$20 trillion between 2015 and 2030 , according to
Read more.
China Leads Global Fintech Investments
China Leads Global Fintech Investments
Investments in Asia-Pacific financial technology (fintech) ventures, primarily in China , reached $9.62 billion as of July 31, more than
Read more.
CSPC Pharmaceutical Announces 2016 Interim Results
CSPC Pharmaceutical Announces 2016 Interim Results
Profit attributable to shareholders increased 25.6% to HK$1,033 million -Innovative Drug Business Maintained Strong Growth Momentum -Common Generic Drug Business
Read more.
East Asia Pacific Growth Remains Resilient
Growth in developing East Asia and Pacific has remained resilient and is expected to ease only modestly during 2016-18, according
Read more.